ResearcherShanghai Jiao Tong UniversityActive in the last 2 years
Liangchao Zhao
Matched on OpenAlex author ID A5108265732. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 4
- Development and Validation of the Predictive and Prognostic ChemoResist Signature in Resected Pancreatic Ductal Adenocarcinoma: Multicohort Study. Co-author DOI 10.1097/sla.0000000000006610↗
- Gene signature developed for predicting early relapse and survival in early-stage pancreatic cancer. Co-author DOI 10.1093/bjsopen/zrad031↗
- Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3389/fonc.2022.827051↗
- TMEM45B promotes proliferation, invasion and migration and inhibits apoptosis in pancreatic cancer cells. Co-author DOI 10.1039/c6mb00203j↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lei Huang · 2 shared papers, 2023–2025 · strength 0.47
- Quanli Han · 2 shared papers, 2023–2025 · strength 0.47
- Yan Xia Shi · 2 shared papers, 2023–2025 · strength 0.47
- Guanghai Dai · 2 shared papers, 2023–2025 · strength 0.47
- Shasha Guan · 1 shared paper, 2023 · strength 0.17
- Xinyang Huang · 1 shared paper, 2022 · strength 0.16
- Lifu Wang · 1 shared paper, 2022 · strength 0.16
- Hui Xu · 1 shared paper, 2022 · strength 0.16
- Zhuoxin Wang · 1 shared paper, 2022 · strength 0.16
- Tong Li · 1 shared paper, 2022 · strength 0.16
- Yixun Jin · 1 shared paper, 2022 · strength 0.16
- Qi Wang · 1 shared paper, 2022 · strength 0.16
- Chenghong Peng · 1 shared paper, 2016 · strength 0.07
- Xiaxing Deng · 1 shared paper, 2016 · strength 0.07
- Hao Chen · 1 shared paper, 2016 · strength 0.07
- Baiyong Shen · 1 shared paper, 2016 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.